Search

Steven C. Bishop

Examiner (ID: 17807)

Most Active Art Unit
3202
Art Unit(s)
3202, 2899, 3722, 3209
Total Applications
1994
Issued Applications
1760
Pending Applications
96
Abandoned Applications
138

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8151931 [patent_doc_number] => 08168414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Beta-galactosidase with transgalactosylating activity' [patent_app_type] => utility [patent_app_number] => 12/225626 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 4346 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168414.pdf [firstpage_image] =>[orig_patent_app_number] => 12225626 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/225626
Beta-galactosidase with transgalactosylating activity Mar 26, 2007 Issued
Array ( [id] => 4845923 [patent_doc_number] => 20080182331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made' [patent_app_type] => utility [patent_app_number] => 11/717037 [patent_app_country] => US [patent_app_date] => 2007-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9100 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182331.pdf [firstpage_image] =>[orig_patent_app_number] => 11717037 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/717037
Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made Mar 12, 2007 Abandoned
Array ( [id] => 5132686 [patent_doc_number] => 20070209083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Cell and transgenic animal modelling human antigenic presentation and their uses' [patent_app_type] => utility [patent_app_number] => 11/709838 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11520 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20070209083.pdf [firstpage_image] =>[orig_patent_app_number] => 11709838 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/709838
Cell and transgenic animal modelling human antigenic presentation and their uses Feb 22, 2007 Abandoned
Array ( [id] => 5231471 [patent_doc_number] => 20070293579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'USE OF CARP INHIBITORS FOR THE TREATMENT OF HEART DISEASES' [patent_app_type] => utility [patent_app_number] => 11/676990 [patent_app_country] => US [patent_app_date] => 2007-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4187 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293579.pdf [firstpage_image] =>[orig_patent_app_number] => 11676990 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/676990
USE OF CARP INHIBITORS FOR THE TREATMENT OF HEART DISEASES Feb 19, 2007 Abandoned
Array ( [id] => 8114405 [patent_doc_number] => 08158422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'Erythroid cells producing adult-type β-hemoglobin generated from human embryonic stem cells' [patent_app_type] => utility [patent_app_number] => 11/672724 [patent_app_country] => US [patent_app_date] => 2007-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4267 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158422.pdf [firstpage_image] =>[orig_patent_app_number] => 11672724 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/672724
Erythroid cells producing adult-type β-hemoglobin generated from human embryonic stem cells Feb 7, 2007 Issued
Array ( [id] => 5367847 [patent_doc_number] => 20090305406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Method of cultivation of human mesenchymal stem cells, particularly for the treatment of non-healing fractures, and bioreactor for carrying out this cultivation method' [patent_app_type] => utility [patent_app_number] => 12/162200 [patent_app_country] => US [patent_app_date] => 2007-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16285 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305406.pdf [firstpage_image] =>[orig_patent_app_number] => 12162200 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/162200
Method of cultivation of human mesenchymal stem cells, particularly for the treatment of non-healing fractures, and bioreactor for carrying out this cultivation method Jan 22, 2007 Abandoned
Array ( [id] => 6532337 [patent_doc_number] => 20100221339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Use of a combination of morphine and at least one opiate antagonist to treat opiate dependency and prevent non-oral opiate abuse among opiate addicts' [patent_app_type] => utility [patent_app_number] => 12/161397 [patent_app_country] => US [patent_app_date] => 2007-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3895 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221339.pdf [firstpage_image] =>[orig_patent_app_number] => 12161397 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/161397
Use of a combination of morphine and at least one opiate antagonist to treat opiate dependency and prevent non-oral opiate abuse among opiate addicts Jan 18, 2007 Abandoned
Array ( [id] => 5552709 [patent_doc_number] => 20090286695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'LUMINESCENT STEM CELLS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/160426 [patent_app_country] => US [patent_app_date] => 2007-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 15585 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286695.pdf [firstpage_image] =>[orig_patent_app_number] => 12160426 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/160426
LUMINESCENT STEM CELLS AND USES THEREOF Jan 9, 2007 Abandoned
Array ( [id] => 5100806 [patent_doc_number] => 20070184068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity' [patent_app_type] => utility [patent_app_number] => 11/638664 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 54319 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184068.pdf [firstpage_image] =>[orig_patent_app_number] => 11638664 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/638664
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity Dec 13, 2006 Abandoned
Array ( [id] => 5173858 [patent_doc_number] => 20070074298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Versican and epithelial-mesenchymal interaction' [patent_app_type] => utility [patent_app_number] => 11/636078 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6581 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20070074298.pdf [firstpage_image] =>[orig_patent_app_number] => 11636078 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/636078
Versican and epithelial-mesenchymal interaction Dec 7, 2006 Abandoned
Array ( [id] => 5391707 [patent_doc_number] => 20090209020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'collagenous matrix with improved porosity and tensile strength and preparation method therefore by using mechanical stimulation system' [patent_app_type] => utility [patent_app_number] => 12/084570 [patent_app_country] => US [patent_app_date] => 2006-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4553 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209020.pdf [firstpage_image] =>[orig_patent_app_number] => 12084570 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/084570
collagenous matrix with improved porosity and tensile strength and preparation method therefore by using mechanical stimulation system Nov 5, 2006 Abandoned
Array ( [id] => 4726598 [patent_doc_number] => 20080206139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'DELIVERY SYSTEM FOR DIAGNOSTIC AND THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 11/556574 [patent_app_country] => US [patent_app_date] => 2006-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18602 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206139.pdf [firstpage_image] =>[orig_patent_app_number] => 11556574 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/556574
DELIVERY SYSTEM FOR DIAGNOSTIC AND THERAPEUTIC AGENTS Nov 2, 2006 Abandoned
10/569995 Method of Selecting Animal Models from Animals Which Have Been Subject to Mutagenesis, and the Use of Myb Transcription Factors for Screening Oct 11, 2006 Abandoned
Array ( [id] => 4747648 [patent_doc_number] => 20080092250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Activity-induced pain in animal model of osteoarthritis' [patent_app_type] => utility [patent_app_number] => 11/546714 [patent_app_country] => US [patent_app_date] => 2006-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3412 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20080092250.pdf [firstpage_image] =>[orig_patent_app_number] => 11546714 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/546714
Activity-induced pain in animal model of osteoarthritis Oct 11, 2006 Abandoned
Array ( [id] => 5215608 [patent_doc_number] => 20070104689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Compositions and methods for treating tumors presenting survivin antigens' [patent_app_type] => utility [patent_app_number] => 11/527195 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23826 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20070104689.pdf [firstpage_image] =>[orig_patent_app_number] => 11527195 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/527195
Compositions and methods for treating tumors presenting survivin antigens Sep 25, 2006 Abandoned
Array ( [id] => 5360493 [patent_doc_number] => 20090035287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'ATRIAL NATRIURETIC PEPTIDE (ANP) SPLICE VARIANTS AND METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 12/088132 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 32865 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035287.pdf [firstpage_image] =>[orig_patent_app_number] => 12088132 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/088132
ATRIAL NATRIURETIC PEPTIDE (ANP) SPLICE VARIANTS AND METHODS OF USING SAME Sep 25, 2006 Abandoned
Array ( [id] => 5107046 [patent_doc_number] => 20070065924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Isolated polynucleotide sequence with IRES activity' [patent_app_type] => utility [patent_app_number] => 11/524428 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7962 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065924.pdf [firstpage_image] =>[orig_patent_app_number] => 11524428 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/524428
Isolated polynucleotide sequence with IRES activity Sep 19, 2006 Abandoned
Array ( [id] => 5056908 [patent_doc_number] => 20070059830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Method for creating myeloid cell lines' [patent_app_type] => utility [patent_app_number] => 11/509314 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14540 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059830.pdf [firstpage_image] =>[orig_patent_app_number] => 11509314 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/509314
Method for creating myeloid cell lines Aug 23, 2006 Abandoned
Array ( [id] => 4792680 [patent_doc_number] => 20080293654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Therapeutic methods using Smads' [patent_app_type] => utility [patent_app_number] => 11/499750 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17446 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293654.pdf [firstpage_image] =>[orig_patent_app_number] => 11499750 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/499750
Therapeutic methods using Smads Aug 2, 2006 Abandoned
Array ( [id] => 5074793 [patent_doc_number] => 20070014768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms' [patent_app_type] => utility [patent_app_number] => 11/493429 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 33300 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014768.pdf [firstpage_image] =>[orig_patent_app_number] => 11493429 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/493429
Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms Jul 24, 2006 Abandoned
Menu